✦ LIBER ✦

Bypassing agent prophylaxis for preventing arthropathy in patients with inhibitors

✍ Scribed by B. M. EWENSTEIN; W.-Y. WONG; A. SCHOPPMANN

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bypassing agent regimens and costs for p

✍ A. GRINGERI 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

The application of bypassing-agent proph

✍ L. A. VALENTINO; M. CARCAO; P. MATHEW; C. A. LEISSINGER; E. BERNTORP; V. BLANCHE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Individualization of bypassing agent tre

✍ G. YOUNG; R. BLAIN; P. NAKAGAWA; D. J. NUGENT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

A consensus statement on clinical trials

✍ J. TEITEL; E. BERNTORP; G. DOLAN; K. FISCHER; A. GRINGERI; C. KESSLER; T. LAMBER 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Experiences in the prevention of arthrop

✍ V. JIMENEZ-YUSTE; E. C. RODRIGUEZ-MERCHAN; M. T. ALVAREZ; M. QUINTANA; M. MARTIN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Differential response to bypassing agent

✍ E. BERNTORP 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB